Biosynthesis of Squalene by Introducing Hybrid MVA Pathway in Escherichia coli

Haiyuan LIU,Wei ZHANG,Guihua GONG,Liping XIE,Youjia HU

DOI: https://doi.org/10.16522/j.cnki.cjph.2017.07.004

2017-01-01

Abstract:Squalene is a polyunsaturated triterpene hydrocarbon (C30H50) with six double bonds produced by mevalonate (MVA) pathway or methylerythritol 4-phosphate (MEP) pathway in several organisms and has a variety of pharmacological activities.Metabolic engineering microorganism is an effective method for squalene production.One of the strategies is the introduction of heterologous MVA pathway genes into Escherichia coli and it could significantly improve the productivity of terpenoids.To increase the yield of squalene in E.coli,we introduced hybrid MVA pathway including upper pathway from Enterococcus faecalis and lower pathway from Saccharomyces cerevisiae into BL21 (DE3).Resulted strain YSS17 can produce 0.73 mg/L squalene,4.87-fold higher compared to the control strain YSS2 (0.15 mg/L).To further increase the production of squalene,the alanine110 of the mvaS gene was mutated to glycine so that squalene production of strain YSS 18 was up to 1.0 mg/L.By substitution of T7 promoter of MVA lower pathway with trc promoter,the yield of squalene reached around 0.78 mg/L,a 22％ decrease compared with YSS18.Finally,MVA upper pathway genes were moved to the low-copy-number plasmid pACY2 and engineering strain YSS20 could produce squalene up to 1.68 mg/L,which was approximately 11.2-fold higher than strain YSS2.